1.
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study
by Laakso, M
Diabetologia, 2007-12-14, Vol.51 (3), p.502-511
2.
Oral glucose tolerance test is needed for appropriate classification of glucose regulation in patients with coronary artery disease: a report from the Euro Heart Survey on Diabetes...
by Bartnik, M
Heart (British Cardiac Society), 2007-01, Vol.93 (1), p.72-77
3.
Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes
by Ahrén, Bo
The journal of clinical endocrinology and metabolism, 2004-05, Vol.89 (5), p.2078-2084
4.
5.
Polyol-pathway-dependent disturbances in renal medullary metabolism in experimental insulin-deficient diabetes mellitus in rats
by PALM, F
Diabetologia, 2004, Vol.47 (7), p.1223-1231
6.
Better vascular engraftment and function in pancreatic islets transplanted without prior culture
by OLSSON, R
Diabetologia, 2005, Vol.48 (3), p.469-476
7.
8.
Intensive glucose control and macrovascular outcomes in type 2 diabetes
by Turnbull, F. M
Diabetologia, 2009-08-05, Vol.52 (11), p.2288-2298
9.
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
by Lavalle-González, F. J
Diabetologia, 2013-09-13, Vol.56 (12), p.2582-2592
10.
Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease : sites and mechanisms
by BUGIANESI, E
Diabetologia, 2005, Vol.48 (4), p.634-642
11.
Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol
by Lim, E. L
Diabetologia, 2011-06-09, Vol.54 (10), p.2506-2514
12.
Circulating betatrophin correlates with atherogenic lipid profiles but not with glucose and insulin levels in insulin-resistant individuals
by Fenzl, Anna
Diabetologia, 2014-03-13, Vol.57 (6), p.1204-1208
13.
The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial
by Battelino, T
Diabetologia, 2012-09-11, Vol.55 (12), p.3155-3162
14.
Prediabetes: a high-risk state for diabetes development
by Tabák, Adam G, Dr
The Lancet (British edition), 2012, Vol.379 (9833), p.2279-2290
15.
Impact of different training modalities on glycaemic control and blood lipids in patients with type 2 diabetes: a systematic review and network meta-analysis
by Schwingshackl, Lukas
Diabetologia, 2014-07-05, Vol.57 (9), p.1789-1797
16.
Glucose Variability; Does It Matter?
by Siegelaar, Sarah E
Endocrine reviews, 2010-04, Vol.31 (2), p.171-182
17.
Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study
by Beysen, C
Diabetologia, 2011-12-02, Vol.55 (2), p.432-442
18.
Brain-derived neurotrophic factor (BDNF) and type 2 diabetes
by KRABBE, K. S
Diabetologia, 2007, Vol.50 (2), p.431-438
19.
‘Exercise snacks’ before meals: a novel strategy to improve glycaemic control in individuals with insulin resistance
by Francois, Monique E
Diabetologia, 2014-05-10, Vol.57 (7), p.1437-1445
20.
Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial
by Dungan, Kathleen M, Dr
The Lancet (British edition), 2014, Vol.384 (9951), p.1349-1357
Filter electronic articles 4.301 Hits
Remove Filters
- Diabetes. Impaired Glucose Tolerance
- Endocrine Pancreas. Apud Cells (4.301)
- Science & Technology (3.879)
- Life Sciences & Biomedicine (3.866)
- Humans (3.533)
- Endocrinology & Metabolism (3.279)
- Male (3.127)
- Etiopathogenesis. Screening. Inv... (3.039)
- Female (2.675)
- Middle Aged (1.987)
- Adult (1.811)
- Blood Glucose - Metabolism (1.608)
- Diabetes (1.421)
- Metabolic Diseases (1.085)
- Aged (1.014)
- Animals (975)
- Glucose (958)
- less ...